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Herpes simplex virus type 1 (HSV-1) has the capacity to establish a life-long latent infection in
sensory neurones and also to periodically reactivate from these cells. Since mutant viruses
defective for immediate-early (IE) expression retain the capacity for latency establishment it is
widely assumed that latency is the consequence of a block in IE gene expression. However, it is
not clear whether viral gene expression can precede latency establishment following wild-type
virus infection. In order to address this question we have utilized a reporter mouse model system
to facilitate a historical analysis of viral promoter activation in vivo. This system utilizes
recombinant viruses expressing Cre recombinase under the control of different viral promoters
and the Cre reporter mouse strain ROSA26R. In this model, viral promoter-driven Cre
recombinase mediates a permanent genetic change, resulting in reporter gene activation and
permanent marking of latently infected cells. The analyses of HSV-1 recombinants containing
human cytomegalovirus major immediate-early, ICP0, gC or latency-associated transcript
promoters linked to Cre recombinase in this system have revealed the existence of a population of
neurones that have experienced IE promoter activation prior to the establishment of latency.
INTRODUCTION
Herpes simplex virus type 1 (HSV-1) is a neurotropic
alphaherpesvirus that establishes latency in sensory
neurones innervating the site of primary infection.
During latency, lytic virus gene expression is repressed
and transcription is restricted to the latency-associated
transcripts (LATs). LATs comprise a series of stable
introns of 2.0 and 1.5 kbp, termed major LATs, which
are spliced from a less abundant 8.3 kbp primary
transcript termed minor LAT (reviewed by Wagner &
Bloom, 1997). Major LATs accumulate within neuronal
nuclei and provide a useful marker for the detection of
latently infected neurones. However, estimates of the
number of neurones harbouring virus DNA by in situ
PCR (Maggioncalda et al., 1996; Mehta et al., 1995), laser
capture microdissection (Chen et al., 2002; Wang et al.,
2005) and direct analyses of dispersed neurones (Sawtell,
1997) indicate that LATs are transcribed in only a
fraction (5–33%) of all latently infected cells. The non-
uniform nature of HSV latency is also apparent with
respect to the amount of virus DNA within individual
neurones, which can range from 1 to 100 copies of virus
DNA in the majority of cells with rare neurones
containing more than 1000 copies (Sawtell, 1997). The
significance of this heterogeneity is unclear although high
latent genome copy number may be a predisposing factor
for virus reactivation (Sawtell et al., 1998). Whether the
high genome loads detected during latency are the result
of direct loading from the periphery (Thompson &
Sawtell, 2000) or the consequence of limited virus gene
expression prior to the establishment of latency
(Slobedman et al., 1994) is currently unclear. Despite
the fundamental nature of the question, it has not been
possible to determine whether virus gene expression can
occur prior to the establishment of latency using
conventional techniques that rely on the detection of
lytic cycle gene products at specific time points, since
these promoters are efficiently silenced during latency.
Thus, whilst recombinant viruses expressing reporter
genes under lytic cycle promoter control are useful tools
in the study of viral gene expression in vivo (Lachmann
et al., 1999; Smith et al., 2000; Thompson et al., 2003)
this approach cannot be used to determine whether Published online ahead of print on 16 September 2008 as DOI
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subsequently abort this pathway prior to the establish-
ment of latency.
In order to directly address this issue we have utilized
ROSA26R reporter mice (Soriano, 1999) containing a LacZ
reporter gene whose expression is only induced following
Cre-mediated recombination. Thus, following Cre-recom-
binase expression, cells are permanently genetically marked
and can be identified by virtue of stable reporter gene
expression. In this study, reporter mice have been used in
conjunction with HSV-1 recombinants expressing Cre
recombinase under latent or lytic cycle promoter control to
determine whether viral promoter activity is compatible
with cell survival and the establishment of latency. This
system has revealed that lytic cycle promoter activation can
precede latency establishment in a subpopulation of
latently infected neurones in vivo.
METHODS
Cells and viruses. All viruses are derived from HSV-1 strain SC16
(Hill et al., 1975). Viruses were propagated and assayed on BHK cells
unless stated otherwise. Cell lines were grown in Glasgow’s modified
Eagles medium (GMEM) supplemented with 10% fetal calf serum
(FCS) and 10% tryptose phosphate broth. SUA cells are a Cre
reporter Vero-derived cell line (Rinaldi et al., 1999).
Plasmids. pHD5 is a plasmid designed to allow recombination of
foreign sequences into the US5 (gJ) gene of HSV-1 (Balan et al.,
1994). pGS403 (Smith & Enquist, 2000) is a pBluescript KSII-based
plasmid containing the human cytomegalovirus (HCMV) major
immediate-early promoter (MIEP) driving expression of Cre
recombinase. pGS403n was derived from pGS403, but contains a
single base pair CAG mutation at position 3597, creating an NcoI
restriction site in the initiating ATG codon of the Cre gene. This
mutation was created using a Stratagene QuickChange Site-Directed
Mutagenesis kit. pHD5-CMVCre contains the Cre expressing
cassette derived from pGS403 inserted into the US5 gene in pHD5.
To achieve this, pGS403 was digested with SalIa n dSacII and the
resulting 2.6 kbp fragment end-repaired and cloned into the EcoRV
site of pHD5. pHD5-ICP0Cre contains the HSV-1 ICP0 promoter
(2818 to position +150 with respect to the ICP0 transcription start
site) driving Cre recombinase in the US5 region. This plasmid was
created by substituting the b-galactosidase (b-Gal) gene from
pHD5110ntbGal (Lachmann et al., 1999) with the Cre expression
cassette. The b-Gal gene was excised by digestion with BamHI and
substituted with an end-repaired HindIII–XhoI fragment from
pGS403 containing Cre. pSLAT1 (Lachmann & Efstathiou, 1997)
contains a 4.6 kb PstI–BamHI fragment encompassing major LATs,
derived from HSV-1 SC16 BamHI B (HSV-1 118867–123460) cloned
into pBluescript M132 (Stratagene). pSLAT1bgeo (Lachmann &
Efstathiou, 1997) was derived from pSLAT1, but contains the
encephalomyocarditis virus (EMCV) internal ribosome entry site
(IRES) linked to a LacZ–neoR gene fusion (bgeo)c l o n e di n t oa
168 bp HpaI deletion (HSV-1 120301–120469). pSLATCre contains
the Cre recombinase gene under LAT promoter control.
pSLAT1bgeo was digested with BbvCI, end-repaired and redigested
with NcoIt oe x c i s et h ebgeo gene. pGS403n was digested with XhoI,
end-repaired and redigested with NcoI, to excise the Cre gene, which
was then cloned into NcoI/BbvCI-digested pSLAT1bgeo. To generate
pGS-gC-403, the HSV-1 gC promoter [2200 to +124 relative to the
gC transcription start site (Weir & Narayanan, 1990) HSV-1 95968–
96296], was amplified by PCR from the HSV-1 strain 17 KpnID
fragment using the following primers: forward 59-
TTTGAGCTCGAATTCTTCTTCTCCGTACGCGCTG-39 and reverse
59-TTTAAGCTTCCTCGCGAGGGATCGGCCTA-39. These primers
introduced novel SacIa n dEcoRI restriction sites upstream of the gC
promoter and a HindIII site was inserted downstream. The PCR
fragment corresponding to the gC promoter was digested with SacI/
HindIII and inserted into the SacI/HindIII sites in pGS403 placing
Cre under control of the gC promoter. pHD5-gCCre contains the gC
promoter-driven Cre recombinase inserted into the US5 region of
HSV-1. pGS-gC-403 was digested with EcoRI/KpnI and the fragment
containing the gC promoter Cre cassette cloned into EcoRI/KpnI
cleaved pHD5.
Construction and characterization of recombinant viruses.
HSV BE8 and HSV C3b contain an HCMV MIEP LacZ cassette
inserted into the US5 locus and the 168 bp HpaI deletion in the LAT
region (HSV-1 120301–120469), respectively (Balan et al., 1994;
Lachmann & Efstathiou, 1997). HSV CMV Cre was constructed by
co-transfecting pHD5-CMVCre and HSV BE8-infected cell DNA,
producing a virus that contains the HCMV MIEP Cre recombinase
cassette inserted at the US5 locus at the SstI restriction site at
genomic coordinate 137946. HSV LAT Cre was generated by co-
transfecting pSLATCre and HSV C3b-infected cell DNA, thus
inserting the Cre recombinase gene together with the EMCV-IRES
1.5 kb downstream of the LAT transcription start site. This virus
thereby encodes Cre under the control of the LAT promoter. To
produce HSV gC Cre, pHD5gCCre and HSV BE8-infected cell DNA
were transfected into cells. The recombinant virus generated encodes
Cre recombinase under gC promoter control at the US5 locus. The
late kinetics of gC promoter-driven Cre transcription was confirmed
by real-time PCR (data not shown). HSV ICP0 Cre was constructed
by co-transfection of pHD5ICP0Cre and WT SC16-infected cell
DNA. This recombinant virus contains the ICP0 promoter upstream
of Cre recombinase inserted into the SstI site at the US5 locus. In all
cases, cell monolayers were harvested 3 days post-transfection and
recombinant virus progeny selected based on failure to stain positive
for b-Gal (HSV CMV Cre, HSV LAT Cre and HSV gC Cre) when
compared with parental viruses (BE8 and C3b). HSV ICP0 Cre was
selected based on its ability to switch on b-Gal expression in SUA
cells. Virus recombinants were isolated and plaque purified by
limiting dilution. Viral genomic structures (Fig. 1) were confirmed
by restriction endonuclease digestion and Southern blot hybridiza-
tion (data not shown). One-step growth curves were performed as
described previously (Lachmann et al., 1996).
In vivo studies used 7- to 8-week-old female BALB/c mice (Harlan).
Mice under isoflurane anaesthesia were infected with 10
6 p.f.u. of either
WTorrecombinant virus in20 mlGMEMbyscarificationoftheleftear.
At various time points, groups of five mice were killed by CO2
asphyxiation. Left ear pinna and cervical dorsal root ganglia CII, CIII
and CIVweredissected and placed into1 ml mediumfor viral titrations
a n ds t o r e da t– 7 0uC prior to assay. Ganglia for explant reactivation
assays were placed in 1 ml GMEM containing 10% FCS and incubated
for 5 days at 37 uC in a gassed 5% CO2 incubator. Explanted ganglia
were then freeze–thaw and homogenized prior to assay. For the
measurement of latent virus DNA loads, CII, CIII and CIV ganglia from
five mice were pooled into TE (10 mM Tris, 1 mM EDTA pH 8.0) and
frozen at 270 uC prior to DNA extraction. All animal experiments were
performed under Home Office Project Licence 80/1806.
ROSA26R reporter mice (Soriano, 1999) were used for the in vivo
characterization of HSV recombinants encoding Cre recombinase.
Groups of adult mice (.8 weeks of age) that differed in age by less
than 12 days were infected with 2610
6 p.f.u. of virus by scarification
of the left ear. At various times after infection mice were killed and
CII, CIII and CIV cervical ganglia pooled and fixed on ice for 1 h in
J. Proenc ¸a and others
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previously (Lachmann & Efstathiou, 1997) or embedded in paraffin
for in situ hybridization analyses by using major LAT-specific
digoxigenin-labelled probes (Arthur et al., 1993; Lachmann &
Efstathiou, 1997).
DNA extraction for quantitative real-time PCR. Pooled CII, CIII
and CIV sensory ganglia from five mice were homogenized and
incubated in 0.5% SDS, 50 mg proteinase K ml
21 in TE overnight at
37 uC. DNA samples were subjected to phenol/chloroform extrac-
tion followed by column purification using Qiagen PCR purification
kit. Real-time PCR was performed as described previously (Coleman
et al., 2008) using adenine phosphoribosyltransferase (APRT) and
ICP0 promoter-specific primer sets. APRT forward primer (nt 585–
604), reverse primer (nt 706–688) (Dush et al., 1985) and Taqman
probe (nt 667–640). ICP0 primers as described in Coleman et al.
(2008).
Statistical analysis. Statistical differences between the numbers of
marked cells per sensory ganglia from mice sampled at different time
points were determined by the Mann–Whitney test.
RESULTS
In vitro and in vivo characterization of HSV-1
based recombinants encoding Cre recombinase
Viruses expressing Cre recombinase under HCMV MIEP,
LAT, ICP0 IE and gC late promoter control were
constructed on an HSV-1 SC16 background as described
in Methods. Schematic representations of the ROSA26R
locus and recombinant virus structures are shown in Fig.
1(a, b). All recombinants replicated with wild-type (WT)
kinetics in vitro (Fig. 1c) and acute phase replication
kinetics in the ears and CII, CIII and CIV sensory ganglia of
mice revealed no obvious growth deficit of recombinant
viruses (Fig. 2). Real-time PCR-based quantification of
latent DNA loads in sensory ganglia and explant reactiva-
tion assays revealed that all recombinants established
latency to WT levels (Fig. 3). These data indicate that the
recombinant viruses are phenotypically indistinguishable
Fig. 1. (a) Structure of the ROSA26 locus in Cre reporter mice. The transgene contains a splice acceptor sequence (SA)
upstream of a neomycin gene (neo) flanked by loxP sites and downstream of a LacZ gene. Following Cre recombination, the
neo gene is removed and the LacZ gene is constitutively expressed by the ROSA26 promoter. (b) Genomic structures of Cre
expressing viruses: HSV CMV Cre, HSV ICP0 Cre and HSV gC Cre have a Cre expression cassette inserted in the non-
essential US5 region. This cassette contains the promoter of interest upstream of Cre recombinase. The Cre gene is fused to a
nuclear localization signal and contains an intron 578 bp downstream of the transcription start site. The HSV LAT Cre virus
contains an IRES-linked Cre gene inserted 1.5 kb downstream of the LAT transcription start site, placing Cre under LAT
promoter control. (c) Single-step growth curves of recombinants, parental viruses and WT strain SC16 are from a single
experiment performed in BHK cells.
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observations concerning the lack of detectable phenotypes
of viruses carrying gene insertions 1.5 kb downstream of
the LAT transcription start site (Lachmann & Efstathiou,
1997) or US5 gene loci (Balan et al., 1994; Thompson et al.,
2003).
Reporter mice facilitate the marking of latently
infected neurones following infection with HSV
CMV Cre
We next determined whether HSV-1 recombinants encod-
ing Cre recombinase could activate reporter gene expres-
sion in the nervous system of ROSA26R mice. Our initial
attention focused on the HCMV MIEP Cre recombinant
(HSV CMV Cre) since previous studies have shown that
this powerful promoter is transiently active prior to the
establishment of latency in cultured sensory neurones
(Arthur et al., 2001) and unlike HSV IE promoters,
activation of the HCMV MIEP is not dependent on the
HSV virion transactivator VP16. ROSA26R mice were
infected with HSV CMV Cre and following resolution of
acute infection, latently infected cervical dorsal root ganglia
were stained for LacZ expression. In this mouse strain,
expression of Cre recombinase mediates recombination
and excision of the loxP flanked neomycin resistance gene
Fig. 2. In vivo pathogenicity studies. Virus titres in ears and pooled CII, CIII and CIV ganglia of BALB/c mice sampled at the
indicated time points. Data points represent average viral titres from five mice±SEM for each recombinant and WT SC16. Each
panel represents an independent experiment.
Fig. 3. Latent DNA loads and explant reactivation capability of virus recombinants. (a, b, c) Latent DNA loads: real-time PCR
was performed on DNA extracted from latently infected ganglia (CII, CIII and CIV pooled from five mice) using as targets ICP0
and APRT. Values represent the mean±SEM of the numbers of the HSV genome copies per 10
4 copies of APRT of three real-
time PCRs. (d, e, f) Viral explants reactivation titres: CII, CIII and CIV ganglia from latently infected mice were explant cultured for
5 days and assayed for reactivated virus. Symbols represent viral titres detected per mouse and the bars are their mean.
J. Proenc ¸a and others
2968 Journal of General Virology 89located between the promoter and the reporter gene,
resulting in constitutive LacZ expression. Of importance to
these studies is the recognition that transient viral Cre
recombinase expression results in the permanent genetic
marking and identification of latently infected neurones.
Infected mice (n57) were sampled 28 days post-infection
(p.i.) and pooled CII, III and IV sensory ganglia were
examined for reporter gene expression. In contrast to the
rapid shutdown of reporter gene expression in neurones
both in vitro and in vivo following infection with
recombinants containing an HCMV MIEP-driven reporter
gene (Arthur et al., 2001; Balliet et al., 2007; Scarpini et al.,
2001; Smith et al., 2000), CMV Cre-induced reporter gene
expression was readily detected during latency in sensory
ganglia [mean 108.89 b-Gal-positive neurones per gan-
glion±7.04 (SEM)] of ROSA26R mice (Fig. 4a). This result
indicates that HCMV MIEP-driven Cre expression in the
context of HSV-1 can mediate loxP recombination and
subsequent reporter gene activation during the establish-
ment of latency. In order to examine the stability of this
population of marked cells, ROSA26R mice were infected
and sampled at either 5, 29 or 147 days p.i. Examination of
pooled sensory ganglia stained for b-Gal (Fig. 4b, c)
revealed positively stained cells during acute infection (day
5) with an average of 140.3±17 b-Gal-positive neurones
per ganglion. At both 29 and 147 days p.i. similar numbers
of b-Gal-positive neurones per ganglion were detected with
mean counts of 87.3±9 and 83.9±10.2, respectively. The
reduction in the number of marked cells observed between
day 5 and latent time points is likely to reflect the death
and loss of productively infected cells. The stability and
number of marked neurones at latent time points suggests
that HCMV MIEP-driven Cre expression results in the
stable marking of a large cohort of latently infected cells. In
order to determine the relationship between the number of
reporter gene-positive neurones and neurones expressing
LATs, pooled sensory ganglia were sampled from groups of
five mice and either stained for b-Gal or processed for in
situ detection of LATs (Fig. 4d, e). Ganglia from mice
sampled 5 months p.i. were sectioned and the number of
b-Gal-positive or LAT-positive neuronal profiles per
ganglionic section enumerated. In situ hybridization
identified an average of 1.05 LAT-positive neuronal profiles
per ganglionic section (n546), whereas histochemical
analyses revealed 9.7 b-Gal-positive neuronal profiles per
ganglionic section (n5127). The number of b-Gal-positive
profiles per ganglionic section was approximately ninefold
greater than the number of LAT-positive neuronal profiles,
Fig. 4. In vivo reporter gene activation by HSV
CMV Cre. (a, b) Number of positive cells per
ganglia from two independent experiments,
each symbol represents a dorsal root ganglion
and the bar represents the mean cell count. (c)
Light micrographs of X-Gal stained sensory
ganglia at 5, 29 and 147 days p.i. (d) LAT in
situ hybridization of ganglionic sections
sampled from mice 5 months p.i. revealed an
average of 1.05 LAT-positive cells per gangli-
onic profile. (e) Sections of X-Gal stained
ganglia from the same experimental group of
mice, revealed an average of 9.7 b-Gal-
positive cells per ganglionic profile.
Viral gene expression can precede latency
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more sensitive method by which to identify latently
infected cells than conventional in situ detection of LATs.
Given that independent studies have reported that in situ
detection of LATs reveals approximately 1/3 of all neurones
containing HSV DNA (Maggioncalda et al., 1996; Mehta et
al., 1995), we conclude that reporter gene activation by
HCMV MIEP Cre expression is likely to mark the majority
of latently infected neurones in vivo.
Previous reports describing the detection of LATs in only a
proportion of latently infected neurones may reflect the
relative insensitivity of conventional hybridization meth-
ods to detect low-level LAT transcription (Ramakrishnan et
al., 1996) or the existence of a population of latently
infected neurones in which the LAT promoter is inactive at
a given time point. In order to distinguish between these
possibilities we next examined a recombinant virus
encoding Cre recombinase under LAT promoter control
in order to determine the number of neurones that
experience LAT promoter activity during the establishment
of latency.
Reporter mice facilitate the marking of a large
reservoir of latently infected neurones following
infection with HSV LAT Cre
ROSA26R mice were infected with a recombinant virus
expressing Cre recombinase under LAT promoter control.
In this construct an IRES-linked Cre gene was inserted
1.5 kb downstream of the LAT transcription start site.
Insertion of reporter genes at this locus has been shown
previously to result in long-term neuronal transgene
expression in the context of both WT virus (Lachmann
& Efstathiou, 1997) and replication defective HSV-1
(Marshall et al., 2000; Scarpini et al., 2001). In contrast
to the HCMV MIEP, which resulted in the marking of large
numbers of neurones during the acute stage of infection,
the HSV LAT Cre recombinant resulted in the marking of
only a small number of neurones per ganglion (mean
5.6±1.9) (Fig. 5a, b). Thus, the small number of neurones
marked by the LAT promoter, most likely reflect the slow
activation of this promoter during the early stages of
latency establishment. By 15 days p.i., the number of
marked cells had increased to a mean of 60±6.3 and
thereafter stabilized with 84±8.5 and 82.4±8 marked cells
per ganglion detected at 32 and 70 days p.i., respectively
(Fig. 5a, b).
Infection of ROSA26R mice with HSV ICP0 Cre
identifies a stable population of latently infected
neurones during latency
In order to determine whether HSV-1 IE ICP0 promoter
activation during latency establishment is compatible with
cell survival, we constructed an HSV recombinant
encoding Cre under ICP0 promoter control. Previous
studies have demonstrated that ICP0 promoter-reporter
constructs accurately reflect the pattern of ICP0 protein
expression from the endogenous gene during acute
Fig. 5. In vivo reporter gene activation by HSV
LAT Cre virus. (a) Representative light micro-
graphs of cervical ganglia stained with X-Gal
at 5, 15 and 32 days p.i. (b) The number of
LacZ-positive cells per ganglion at 5, 15, 32
and 70 days p.i. The symbols represent the
number of positive cells in each ganglia and
the bar represents the mean number of b-Gal-
positive cells.
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vivo (Thompson et al., 2003). Furthermore, such promoter-
reporter constructs are efficiently silenced during latency
(Lachmann et al., 1999; Shimeld et al., 2001; Thompson
et al., 2003). ROSA26R mice infected with HSV ICP0 Cre
were sampled at acute (day 7 p.i.) and latent (day 30 and
65 p.i.) time points. Sensory ganglia were pooled from
five mice and stained for b-Gal expression (Fig. 6a). At
day 7 p.i., 70.2±8.4 b-Gal-positive neurones per ganglion
were identified (Fig. 6b). Since day 7 p.i. represents an
acute stage of infection it was considered likely that these
b-Gal-positive neurones corresponded to productively
infected cells, which would be eliminated as the infection
progressed. Significantly, the number of b-Gal-positive
neurones per ganglion decreased to 30.1±3 at day 30 p.i.
and remained at a relatively stable level thereafter with
28.1±4.6 neurones per ganglion labelled at 65 days p.i.
(Fig. 6b). The number of cells marked during latency was
confirmed in an independent experiment, which iden-
tified 154±32.5 marked cells at the peak of acute
infection (day 5 p.i.), and 37.9±7.7 marked neurones
per ganglion at 39 days p.i. (Fig. 6c). This result suggests
that approximately 35% of neurones marked by either
HCMV IE or LAT promoter-driven Cre expression are
likely to have experienced ICP0 promoter activation prior
to the establishment of latency.
In contrast with HSV ICP0 Cre, infection of reporter mice
with an HSV-1 recombinant expressing Cre under the
control of the late gC promoter resulted in a low level of
neuronal marking at the acute day 5 time point (7.8±1.5
LacZ-positive neurones per ganglion) (Fig. 6d, e).
Furthermore, an even lower level was observed at days 30
and 124 latent time points, which revealed 1.9±0.35 and
2±0.36 b-Gal-positive neurones per ganglion, respectively.
These data indicate that late promoter activation of Cre
expression is largely incompatible with cell survival.
DISCUSSION
In this paper ROSA26R reporter mice have been used in
conjunction with HSV-1 recombinants expressing Cre
recombinase to genetically mark neuronal cells. This
approach to studying HSV pathogenesis and latency has
significant advantages over the use of viruses expressing
reporter genes under the control of HSV-1 promoters since
such recombinants only facilitate the examination of
reporter gene expression in tissues at defined time points
Fig. 6. In vivo reporter gene activation by HSV ICP0 Cre and HSV gC Cre recombinant viruses. (a) Representative
micrographs of histochemical detection of b-Gal in the dorsal root ganglia of reporter mice infected with HSV ICP0 Cre at 7, 30
and 65 days p.i. (b, c) Numbers of LacZ-positive cells per ganglion marked by HSV ICP0 Cre from two independent
experiments at the specified time points. Symbols represent the number of positive cells in a single ganglion and the bars the
mean number of b-Gal-positive cells at the indicated times. (d) Representative micrographs of histochemical detection of b-Gal
in sensory ganglia of reporter mice infected with the HSV gC Cre recombinant at 32 days p.i. (e) Numbers of positive cells per
ganglion at 5, 32 and 124 days p.i. with HSV gC Cre virus.
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2003). This limits their utility in studies of pathogenesis
since lytic cycle promoters are silenced during latency.
Thus, the question of whether lytic cycle promoter activity
can be tolerated by neurones prior to the establishment of
latency remains largely unexplored.
Infection of reporter mice with HSV CMV Cre resulted in
the efficient marking of sensory neurones that extended
from the acute to latent phase of infection. The mean
number of marked neurones per ganglion at the acute day
5 time point exceeded the number of cells marked at days
30 and 150 latent time points by 1.6-fold (P50.031). The
higher numbers detected during the acute stage is likely to
be due to the marking of both acutely infected cells, which
are destined to die as a result of productive infection, in
addition to a cohort of cells that have experienced transient
HCMV MIEP activation prior to the establishment of
latency. This is consistent with the view that lytic and latent
pathways of gene expression in neurones diverge from each
other during acute ganglionic infection (Margolis et al.,
1992; Speck & Simmons, 1992). The efficient silencing of
the HCMV MIEP in the context of HSV-1 latency is well
established (Arthur et al., 2001; Balliet et al., 2007; Scarpini
et al., 2001; Smith et al., 2000) thus, the observation that
there is no significant change in the average number of
marked cells from days 30 (mean 87.3±9) to 150 p.i.
(mean 83.9±10.2) (P50.98) suggests that HCMV MIEP
Cre expression marks a stable population of neurones that
survived the initial infection. At present, we have no direct
evidence that this population of marked cells represents the
total reservoir of neurones containing latent HSV DNA.
Nonetheless, our observations that the number of b-Gal-
positive cells exceeds by ninefold the number of LAT-
positive cells detected by in situ hybridization, together
with previous reports demonstrating that only approxi-
mately 1/3 of all neurones containing HSV DNA express
detectable levels of LATs (Maggioncalda et al., 1996; Mehta
et al., 1995) suggests that HCMV MIEP-driven Cre
expression is likely to have marked the majority of latently
infected cells. Of significance, recent data using reporter
mice in studies of HSV latency have revealed that the
average viral copy number per cell marked with a WT
HSV-1 CMV IE Cre construct is 38 genomes per cell
(Wakim et al., 2008), which is similar to estimates from
single-cell analyses (Sawtell et al., 1998; Chen et al., 2002).
These data provide additional evidence of the high
efficiency of cell marking achievable with Cre expressing
viral constructs in reporter mice.
Expression of Cre recombinase from the LAT promoter
resulted in a distinct kinetic of cell marking in comparison
to that observed using the HCMV MIEP construct. Thus,
only small numbers of neurones were marked at the acute
stage of infection and there was a significant increase in the
number of marked cells from the acute (day 5) to the latent
time points (day 30, P50.000013; day 70 P50.000037)
with stable numbers of b-Gal-positive cells being observed
from days 30 (mean 84±8.5) to 70 p.i. (mean 82.4±8).
The number of cells marked by HSV LAT Cre and HSV
CMV Cre are similar during latency, suggesting that the
majority of infected neurones experience LAT promoter
activation during the first 30 days after infection. In
contrast, expression of LacZ under LAT promoter control
in a virus context has previously shown to mark relatively
small numbers of latently infected neurones (Lachmann &
Efstathiou, 1997). Thus, methodologies relying on direct
assays of promoter activity at specific time points rather
than historical measures, are likely to have underestimated
the total proportion of cells that can experience promoter
activity over a prolonged time frame.
Of particular interest was the observation that HSV ICP0
Cre was able to mark a stable population of neurones
during latency. For the following reasons we consider it
likely that these neurones represent cells that experienced
activation of this IE promoter prior to the establishment of
latency. (i) Previous in vivo studies examining the activity
of the ICP0 promoter during latency using HSV recombi-
nants encoding ICP0 promoter-reporter gene constructs
resulted in the detection of few, if any reporter gene-
positive neurones during latency (Lachmann et al., 1999;
Shimeld et al., 2001; Thompson et al., 2003). These data
support the view that the ICP0 promoter is effectively
silenced during latency. Therefore, the marking of a large
reservoir of latently infected cells in this system is most
likely due to transient activation of the ICP0 promoter in a
specific subpopulation of cells during latency establishment
rather than a result of ongoing ICP0 promoter activity
during established latency. (ii) HSV ICP0 Cre marked an
average of 30.1 and 28.1 LacZ-positive neurones per
ganglion at days 30 and 65, respectively, which constitutes
approximately 1/3 of the total latent reservoir as defined by
the number of neurones marked by the HSV CMV or HSV
LAT Cre recombinants. (iii) In the unlikely event that this
marking is due to low-level transcription during latency it
is necessary to point out that this expression starts very
early in latency, all cells are marked by day 30, and it is
restricted to a stable subpopulation of infected cells.
This stability of cell marking implies the existence of two
populations of latently infected cells that had either
experienced or not, prior ICP0-mediated reporter gene
activation.
The low efficiency of cell marking by the HSV gC Cre
recombinant during acute infection was unexpected since
this virus has no detectable phenotype either in vitro or in
vivo. Therefore, the failure to observe large numbers of b-
Gal-positive cells within ganglia at day 5 is unlikely to be a
consequence of virus attenuation. A more likely explana-
tion is that virus-induced host cell shut off and cell death
precluded reporter gene activation at this acute time point,
resulting in an underestimate of the number of infected
cells. Thus, the late kinetics of Cre recombinase expression
may prove to be incompatible with efficient cell marking
during lytic infection as a consequence of virus-induced
cytopathic effects. This view is supported by the marked
J. Proenc ¸a and others
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reporter gene expression following infection of the SUA
reporter cell line (Rinaldi et al., 1999) in comparison to the
ICP0 and CMV Cre recombinants (data not shown).
Previous studies on the frequency of spontaneous in vivo
reactivation have estimated that reactivation occurs in
approximately 1 out of every 50–90000 latently infected
neurones or 1 reactivating neurone per 10–17 ganglia
(Feldman et al., 2002; Sawtell, 2003). In the current study,
the frequency of b-Gal-positive neurones revealed by using
the HSV gC Cre virus is 1.9–2 per ganglion during latency,
which is at least 10-fold higher than the expected frequency of
spontaneous reactivation. One possible explanation for this
high frequency of markingbythe HSV gC Cre recombinant is
that the small, but stable, population of b-Gal-positive
neurones observed during latency constitute cells that have
survived late gene expression, possibly as a result of non-
cytolyticCD8T-mediatedabrogationofreplication(Sheridan
et al., 2007; Simmons & Tscharke, 1992).
Mechanistically, the most widely accepted view of latency
establishment is that it is the result of a failure of IE gene
activation (Efstathiou & Preston, 2005; Garcia-Blanco &
Cullen, 1991; Knipe & Cliffe, 2008). It is therefore of
interest that the reporter mouse system identified a cohort
of latently infected cells that had experienced prior ICP0
promoter activation since ICP0 is a major transcriptional
activator that plays an important role in the initiation of
lytic cycle replication and reactivation (reviewed by Everett,
2000). As there is increasing evidence that HSV utilizes
post-transcriptional regulatory strategies (Thompson et al.,
2003; Umbach et al., 2008) a key issue will now be to
determine whether the ICP0 promoter mediated Cre
expression accurately reflects ICP0 protein expression
during neuronal infection in vivo. Nonetheless, previous
studies utilizing an in vitro neuronal latency model system
have suggested that ICP0 gene expression can precede
latency establishment raising the possibility that neurones
can tolerate some degree of lytic gene expression prior to
the establishment of latency (Arthur et al., 2001).
Furthermore, there is evidence to suggest that the efficient
establishment of HSV-1 latency is dependent on ICP0
expression (Wilcox et al., 1990). In conjunction with the
data reported in the current study it seems likely that HSV
can follow at least two pathways into latency: one that is
preceded by ICP0 promoter activation and another that
follows a default pathway with no prior evidence of IE
promoter activation. It will therefore be of considerable
interest to determine whether the cell marking observed
with the ICP0 promoter can be extended to other IE or E
virus promoters and to determine the biological conse-
quences of such promoter activation. Since only small
numbers of latently infected cells are competent for virus
reactivation, it will now be possible to determine whether
populations of latently infected cells that have experienced
different degrees of virus promoter activation prior to the
establishment of latency represent cells with an altered
propensity for reactivation. In addition, the marking of
different subsets of latently infected cells using reporter
mice offers a potentially powerful system for the isolation
and biochemical characterization of latently infected
neuronal subsets.
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